Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Percheron Therapeutics ( (AU:PER) ) has provided an update.
Percheron Therapeutics Limited has announced the cessation of certain securities, specifically options that expired without being exercised or converted. A total of 14.5 million options, with varying exercise prices, have expired as of March 18, 2025. This announcement may impact the company’s capital structure and could influence investor perception regarding the company’s financial strategies.
More about Percheron Therapeutics
Average Trading Volume: 10,000
Technical Sentiment Consensus Rating: Sell
Current Market Cap: $7.63M
See more data about PER stock on TipRanks’ Stock Analysis page.